AGYA Member

Mohamed Abou El-Enein

Medical and Health Sciences

Areas of Expertise for Media Inquiries:
Regenerative Medicine, Clinical Research, Regulatory Science, Global Health


About me

I am currently Junior-Professor of clinical development with focus on regenerative medicine and head of the clinical development platform at Berlin-Brandenburg Center for Regenerative Therapies (BCRT) at the Charité University Hospital in Berlin. The platform is responsible for transforming the research findings of the scientists into clinical applications. I also serve as a Teaching Assistant in clinical research at Harvard T.H. Chan School of Public Health and Instructor in Translational Medicine and Regulatory Science at the Berlin-Brandenburg School for Regenerative Therapies (BSRT). My primary research interests focus on the development and clinical translation of cell and gene therapies. I am also a strong advocate for policies that improve the access to novel biotechnologies to confront global health issues.

 


Current projects

Recently, the development of regenerative medicine applications, including stem cell-based therapies, has been rapidly advancing and this has led to an increase in the unregulated stem cell treatments that are offered to desperate patients without proof of safety and efficacy (referred to as stem cell tourism). This has been facilitated by the absence of internationally harmonized regulatory frameworks that govern research and clinical use of these products, especially in the Arab countries. My aim is to establish a transnational network that advocate new forms of research regulation, ethical standards and increase public awareness across the Arab nations in the field of regenerative medicine by using Germany as a role model.


Academic Career

2017 - Junior Professor at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin; Germany
2015 - Head of the Clinical Development Platform (CDP) and Group Leader at BCRT, Charité - Universitätsmedizin Berlin; Germany
2015 Teaching Assistant in Clinical Research at Harvard T.H. Chan School of Public Health; Boston, USA
2014 PhD (dr. med) at BCRT, Charité - Universitätsmedizin Berlin;Germany
2014 MA of Pharmaceutical Sciences and Technologies at the University of Strasburg; France
2013 Project Manager at the Clinical Development Platform (CDP), BCRT, Charité - Universitätsmedizin Berlin; Germany
2010 - 2013 Doctoral Researcher at (BCRT), Charité - Universitätsmedizin Berlin; Germany
2007
Postgraduate Diploma (PgDip) at Quality Management Institute, American University Cairo; Egypt

 


Selected Publications

     

  • Abou-El-Enein, M. & Schneider, C. K. (2016). Deciphering the EU clinical trials regulation. Nature Biotechnology 34(03), 6-9.
  • Abou-El-Enein, M., Bauer, G., Reinke, P., Renner, M. & Schneider, C. K. (2014). A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV. Trends in Molecular Medicine 11(20), 632-642. DOI:10.1016/j.molmed.2014.08.004
  • Abou-El-Enein, M., Bauer, G. & Reinke, P. (2014). The business case for cell and gene therapies. Nature Biotechnology 32(12), 1192–1193. DOI:10.1038/nbt.3084
  •  


see a full list of publications>

Contact

Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité

Charité - Universitätsmedizin Berlin Campus Virchow-Klinikum Augustenburger Platz 1 (Südstraße 2) 13353 Berlin

+49 30 450 539 594
mohamed.abou-el-enein(at)charite.de

visit profile at home institute >

Sponsored by